Enjoy complimentary customisation on priority with our Enterprise License!
Want to get a preview about how you can gain crucial information from Technavio’s market research report? Check out the latest facts about the peanut allergy therapeutics industry
Peanut allergy industry growth is expected to grow at a mammoth rate over the next five years driven by the increase in collaborations for R&D. Drug development and marketing is an expensive and lengthy affair in the pharmaceutical industry as the peanut allergy therapy companies need extensive funding, advanced manufacturing units, and a strong distribution network. Several peanut allergy therapy companies are engaging in collaborations to gain a strong foothold on funds and skill set to develop novel peanut allergy treatment methods. Another factor behind the rapid growth of the global peanut allergy market is the growing prevalence of various types of food allergy, including peanut allergy in many developed countries. Technavio’s peanut allergy industry analysis reveals promising markets around the world.
Get a free sample of this report now!
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
The Americas will drive almost 47% of the growth for the global peanut allergy market, while EMEA and APAC are also predicted to make sizeable contributions to the incremental growth in the forecast period. Towards the end of 2018, the Americas dominated the global peanut allergy market with a market share of over 47%, followed by EMEA and APAC. In addition, the Americas are expected to retain their dominant market position through the period of forecast, while, APAC is anticipated to display the fastest rate of growth in comparison to EMEA and the Americas over the next five years.
The global peanut allergy market is forecasted to grow marginally less concentrated over the next five years owing to the presence of a few peanut allergy therapy companies that offer products such as peanut protein and vaccines. Some of the leading peanut allergy therapy companies are conducting extensive R&D on developing drugs and using peanut protein as immunotherapy for peanut allergy. Many international and regional vendors are vying for their share of the peanut allergy market, and players must differentiate themselves to gain vital traction over their peers.
This report offers a complete analysis of several companies, including:
We can help! Our analysts can customize this report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: PIPELINE
PART 07: MARKET SEGMENTATION BY PRODUCT
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
PART 14: VENDOR ANALYSIS
PART 15: APPENDIX
PART 16: EXPLORE TECHNAVIO
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.